BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27836336)

  • 21. Automated algorithm to measure changes in medial temporal lobe volume in Alzheimer disease.
    Kazemifar S; Drozd JJ; Rajakumar N; Borrie MJ; Bartha R;
    J Neurosci Methods; 2014 Apr; 227():35-46. PubMed ID: 24518149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autopsy-confirmed hippocampal-sparing Alzheimer's disease with delusional jealousy as initial manifestation.
    Fujishiro H; Iritani S; Hattori M; Sekiguchi H; Matsunaga S; Habuchi C; Torii Y; Umeda K; Ozaki N; Yoshida M; Fujita K
    Psychogeriatrics; 2015 Sep; 15(3):198-203. PubMed ID: 25737011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
    Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
    Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respective influence of beta-amyloid and APOE ε4 genotype on medial temporal lobe subregions in cognitively unimpaired older adults.
    de Flores R; Demeilliez-Servouin S; Kuhn E; Chauveau L; Landeau B; Delcroix N; Gonneaud J; Vivien D; Chételat G;
    Neurobiol Dis; 2023 Jun; 181():106127. PubMed ID: 37061167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    Jarholm JA; Bjørnerud A; Dalaker TO; Akhavi MS; Kirsebom BE; Pålhaugen L; Nordengen K; Grøntvedt GR; Nakling A; Kalheim LF; Almdahl IS; Tecelão S; Fladby T; Selnes P
    J Alzheimers Dis; 2023; 94(1):259-279. PubMed ID: 37248900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity of different MRI-techniques to assess gray matter atrophy patterns in Alzheimer's disease is region-specific.
    Clerx L; Jacobs HI; Burgmans S; Gronenschild EH; Uylings HB; Echávarri C; Visser PJ; Verhey FR; Aalten P
    Curr Alzheimer Res; 2013 Nov; 10(9):940-51. PubMed ID: 23947582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing the diagnostic accuracy of medial temporal lobe atrophy in Alzheimer's disease.
    Jacobs HI; Van Boxtel MP; van der Elst W; Burgmans S; Smeets F; Gronenschild EH; Verhey FR; Uylings HB; Jolles J
    J Alzheimers Dis; 2011; 25(3):477-90. PubMed ID: 21471642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
    Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA
    Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Risk for Alzheimer's Disease Moderates the Association Between Medial Temporal Lobe Volume and Episodic Memory Performance Among Older Adults.
    Prieto S; Valerio KE; Moody JN; Hayes SM; Hayes JP;
    J Alzheimers Dis; 2020; 76(2):591-600. PubMed ID: 32538837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease.
    Kljajevic V; Grothe MJ; Ewers M; Teipel S;
    Neurobiol Aging; 2014 Sep; 35(9):1973-81. PubMed ID: 24811241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET.
    Mosconi L; De Santi S; Li Y; Li J; Zhan J; Tsui WH; Boppana M; Pupi A; de Leon MJ
    Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):210-21. PubMed ID: 16311757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease.
    Uotani C; Sugimori K; Kobayashi K
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):319-26. PubMed ID: 16732748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
    Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
    Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility and acceptance of simultaneous amyloid PET/MRI.
    Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single time point high-dimensional morphometry in Alzheimer's disease: group statistics on longitudinally acquired data.
    Duchesne S; Valdivia F; Mouiha A; Robitaille N;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S11-22. PubMed ID: 25444598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volumetric GWAS of medial temporal lobe structures identifies an ERC1 locus using ADNI high-resolution T2-weighted MRI data.
    Cong S; Yao X; Huang Z; Risacher SL; Nho K; Saykin AJ; Shen L; ;
    Neurobiol Aging; 2020 Nov; 95():81-93. PubMed ID: 32768867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
    Iizuka T; Kameyama M
    Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease.
    Persson K; Barca ML; Cavallin L; Brækhus A; Knapskog AB; Selbæk G; Engedal K
    Acta Radiol; 2018 Aug; 59(8):997-1001. PubMed ID: 29172642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.